ngµç×ÓÓÎÏ·

05

¿ÆÑÐÏ£Íû

Ö×Áö·ÀÖÎÖÐÐÄѧÕßÍçÇ¿½ÇÁ¦¾Ö²¿ÍíÆÚ±ÇÑÊ°© Êý¶È¸Äд¹ú¼ÊÖ¸ÄÏ

ÔĶÁÁ¿£º£º£º

±ÇÑÊ°©ÊÇÖйúÄÏ·½³£¼ûµÄÍ·¾±Ö×Áö£¬£¬£¬·¢²¡ÒԹ㶫×î¶à£¬£¬£¬Òò´ËÒà³ÆΪ¡°¹ã¶«Áö¡±¡£¡£¡£¡£¡£2017Äêngµç×ÓÓÎÏ·Ö×Áö·ÀÖÎÖÐÐÄÊÕÖεÄз¢±ÇÑÊ°©²¡Àý´ï5609Àý¡£¡£¡£¡£¡£Òź¶µÄÊÇ£¬£¬£¬Áè¼Ý2/3µÄ±ÇÑÊ°©»¼ÕßÔÚ¾ÍÕïʱÒѾ­´¦ÓÚ¾Ö²¿ÇøÓòÍíÆÚ¡£¡£¡£¡£¡£ÏÖÔÚÕⲿ·Ö»¼ÕßµÄÖÎÁÆ»ù±¾ÊÇͬÆÚ·Å»¯ÁÆ£¬£¬£¬µ«ÈÔÓÐÔ¼20%µÄ»¼ÕßÔÚÖÎÁƺó·ºÆðÔ¶´¦×ªÒÆ£¬£¬£¬³ÉΪÖÎÁÆʧ°ÜµÄÖ÷ÒªÔ­Òò¡£¡£¡£¡£¡£

Ê×Ò³|ngµç×ÓÓÎÏ·Öйú¼¯ÍŹٷ½ÍøÕ¾

Âí¿¥½ÌÊÚÑо¿ÍŶÓ

ÓÉngµç×ÓÓÎÏ·Ö×Áö·ÀÖÎÖÐÐÄǣͷ£¬£¬£¬ÁªºÏмÓƹúÁ¢°©Ö¢ÖÐÐÄÒÔ¼°Ïã¸ÛÍþ¶û˹Ç×ÍõÒ½Ôº×é³É±ÇÑÊ°©Ð­×÷С×飬£¬£¬¿ªÕ¹ÁËÒ»Ïî»ùÓÚÓÕµ¼»¯ÁÆËæ»ú±ÈÕÕÁÙ´²ÊÔÑé¸öÌåÊý¾ÝµÄ¹ú¼Ê¶àÖÐÐĺϲ¢ÆÊÎö£¬£¬£¬ÔÚ¹ú¼ÊÉÏÊ×´ÎÈ·¶¨ÓÕµ¼»¯ÁƾßÓÐÈ·ÇÐÁÆЧ¡£¡£¡£¡£¡£Ñо¿Ð§¹ûÓÚ2ÔÂÔÚÏß½ÒÏþÓÚÈ«Çò¶¥¼¶Ö×ÁöרҵÔÓÖ¾¡¶Clinical Cancer Research¡·£¬£¬£¬²¢±»Ñ¡Îªµ±ÆÚÁÁµãÎÄÕ£¨Highlights£©£¨2017ÄêÓ°ÏìÒò×Ó10.2·Ö£©¡£¡£¡£¡£¡£

ÔçÔÚ2008Ä꣬£¬£¬Õë¶Ô¾Ö²¿ÍíÆÚ±ÇÑÊ°©£¬£¬£¬ÃÀ¹úNCCNÖ¸ÄÏƾ֤µÍ·¢ÇøµÄÁÙ´²ÊÔÑéЧ¹û£¬£¬£¬ÍƼöͬÆÚ·Å»¯ÁÆÁªºÏ¸¨Öú»¯ÁÆΪ¾Ö²¿ÍíÆÚ±ÇÑÊ°©µÄ±ê×¼ÖÎÁÆ·½°¸£¨1ÀàÍƼö£©¡£¡£¡£¡£¡£Ôڸ߷¢Çø£¬£¬£¬ngµç×ÓÓÎÏ·Ö×Áö·ÀÖÎÖÐÐÄÂí¿¥½ÌÊڵĿÆÑÐÍŶÓÔÚ2012ÄêÍê³ÉÒ»Ïî¶àÖÐÐÄ3ÆÚÁÙ´²ÊÔÑ飬£¬£¬ÔÚ¹ú¼ÊÉÏÊ×´Î֤ʵ¸¨Öú»¯ÁÆδÄܽøÒ»²½Ìá¸ßÁÆЧ£¬£¬£¬²¢ÇÒ´øÀ´ÏÔ×ŵÄÍÂÄæ¡¢¡¢¡¢ð¤Ä¤Ñ׵ȶ¾¸±·´Ó³£¨Lancet Oncol, 2012£©¡£¡£¡£¡£¡£¸ÃÑо¿½ÒÏþÎôʱ¼´±»Å·ÖÞÖ¸ÄϽÓÄÉ£¬£¬£¬´ÎÄ꣨2013Ä꣩±»ÃÀ¹úÖ¸ÄϽÓÄÉ¡£¡£¡£¡£¡£

È»¶ø£¬£¬£¬ÔõÑùÔÚͬÆÚ·Å»¯ÁƵĻù´¡ÉÏÌá¸ßÁÆЧÉÐÐè½øÒ»²½Ñо¿¡£¡£¡£¡£¡£Òò´Ë£¬£¬£¬ngµç×ÓÓÎÏ·Ö×Áö·ÀÖÎÖÐÐÄÂí¿¥½ÌÊÚ¼°ËïÓ±½ÌÊÚÍŶÓÔÙ½ÓÔÙÀ÷£¬£¬£¬ÔÙ´ÎÒÔÒ»Ïî¶àÖÐÐÄÈýÒ©ÓÕµ¼»¯ÁÆ£¨¶àÎ÷ËûÈü+˳²¬+5-·úÄòà×ण©Ëæ»ú±ÈÕÕÊÔÑ飬£¬£¬ÔÚ¹ú¼ÊÉÏÊ×´Î֤ʵͬÆÚ·Å»¯ÁÆǰʹÓÃÓÕµ¼»¯ÁÆ¿ÉÏÔÖø½µµÍÔ¶´¦×ªÒÆÂʲ¢Ìá¸ß»¼ÕßÉúÑÄ£¨Lancet Oncol, 2016£©¡£¡£¡£¡£¡£Óë´Ëͬʱ£¬£¬£¬ngµç×ÓÓÎÏ·Ö×Áö·ÀÖÎÖÐÐĺéÃ÷»Î½ÌÊÚÍŶÓÒà·¢Ã÷˳²¬+5-·úÄòà×à¤Á½Ò©ÓÕµ¼»¯ÁÆ·½°¸ÓÐDZÔÚÇ÷ÊƽµµÍÔ¶´¦×ªÒÆÂÊ£¨Eur J Cancer, 2017£©£»£»Ëæºó³ÂÃ÷Ô¶½ÌÊÚÍŶӽøÒ»²½Í¨¹ý¸ÃÁÙ´²ÊÔÑ齨ÉèÁË¿ÉÔ¤²âÓÕµ¼»¯ÁÆÁÆЧµÄ·Ö×ÓÄ£×Ó£¨Clin Cancer Res, 2017; Highlights£©¡£¡£¡£¡£¡£

ΪÁË×îÖÕÃ÷È·ÓÕµ¼»¯ÁÆÔÚ¾Ö²¿ÍíÆÚ±ÇÑÊ°©ÖеÄְ룬£¬£¬ÓÉÂí¿¥½ÌÊÚ¡¢¡¢¡¢ºéÃ÷»Î½ÌÊÚǣͷ£¬£¬£¬ÁªºÏмÓƼ°Ïã¸ÛµÄÑо¿Õ߶ԱÇÑÊ°©Ê¢ÐеØÇøµÄ1,193Àý»¼Õß¾ÙÐÐÁ˸öÌåÊý¾ÝºÏ²¢ÆÊÎö£¬£¬£¬·¢Ã÷Ïà¹ØÓÚ´¿´âͬÆÚ·Å»¯ÁÆ£¬£¬£¬ÓÕµ¼»¯ÁÆÁªÌõÔ¼ÆÚ·Å»¯Áƿɽ«»¼ÕßµÄ5ÄêÔ¶´¦×ªÒÆÂʽµµÍ7%£¬£¬£¬5Äê×ÜÉúÑÄÂÊÌá¸ß6%£¬£¬£¬Ã÷È·ÁËÓÕµ¼»¯ÁÆ¿Éͨ¹ý½µµÍ¾Ö²¿ÇøÓòÍíÆÚ±ÇÑÊ°©µÄԶת·çÏÕ¶øת»¯ÎªÉúÑÄ»ñÒ棬£¬£¬È·¶¨ÁËÓÕµ¼»¯ÁÆÔÚ±ÇÑÊ°©ÖÎÁÆÖеÄְλ¡£¡£¡£¡£¡£

»ùÓÚÒÔÉÏÑо¿Ð§¹û£¬£¬£¬2018Ä꣬£¬£¬ÃÀ¹ú×îаæÖ¸ÄÏÒѽ«ÓÕµ¼»¯ÁÆ·½°¸´Ó³ÖÐø8ÄêµÄ3¼¶Ö¤¾ÝÉÏÉýÖÁ2A¼¶Ö¤¾Ý¡£¡£¡£¡£¡£ÍâÑóÖøÃûýÌåbeforeitsnewsµÈÒÔ¡¶±ÇÑÊ°©×ÛºÏÖÎÁÆÀï³Ì±®£º£º£ºÀ´×ÔÖйúѧÕßµÄ×îÐÂÑо¿Ï£Íû¡·£¨Milestones in Chemoradiotherapy Strategy for Nasopharyngeal Carcinoma: Recent Advances by Physicians Mainly from China£©ÎªÌâ¶ÔÂí¿¥½ÌÊÚµÈϵÁÐÑо¿¾ÙÐÐÁ˱¨µÀ¡£¡£¡£¡£¡£

ÒÑÍùÊ®Ä꣬£¬£¬¹ØÓÚ¾Ö²¿ÍíÆÚ±ÇÑÊ°©µÄÖÎÁÆ£¬£¬£¬ÃÀ¹úÖ¸ÄÏƾ֤ngµç×ÓÓÎÏ·Ö×Áö·ÀÖÎÖÐÐĵÄÔ­´´ÐÔÑо¿×ö¹ýÁ½´ÎÖØ´óµ÷½â£º£º£º½µµÍ¸¨Öú»¯ÁƼ°Ìá¸ßÓÕµ¼»¯ÁƵÄÍƼö¡£¡£¡£¡£¡£ÒԺ󣬣¬£¬ngµç×ÓÓÎÏ·Ö×Áö·ÀÖÎÖÐÐÄѧÕß½«¼ÌÐø²»Î·¼èÐÁ£¬£¬£¬ÇóË÷²»Ö¹£¬£¬£¬ÔÚ»ù´¡ºÍÁÙ´²Ñо¿·½Ãæ²½²½Ç°ÐУ¬£¬£¬Íƶ¯±ÇÑÊ°©ÁÙ´²ÕïÁÆÔÚ¸öÌ廯¾«×¼ÕïÁÆʱ´úµÄһֱͻÆÆ£¬£¬£¬Ô츣¿í´ó»¼Õß¡£¡£¡£¡£¡£

Ô­ÎÄÁ´½Ó£º£º£ºhttp://clincancerres.aacrjournals.org/content/24/8/1824.long

¡¾ÍøÕ¾µØͼ¡¿